The leaders ofthe St. Jude Comprehensive Cancer Center (SJCCC) are responsible for setting the Center's strategic goals and establishing a laboratory and clinical research environment that can realize its cancer focused mission. The SJCCC administrative staff provide logistical support to this mission;implementing the plans and policies established to ensure an efficient and productive Center. The Office of SJCCC Administration works closely with the SJCCC Director, Associate Directors of the SJCCC, the Center Program leaders, and Shared Resource Leaders to provide support for the functions required for efficient operation of all Center activities, including the day-to-day operations of the SJCCC Director's office. The Center administration works with the Director to develop and manage all fiscal activities;provide oversight of Center institutional and external funds;participate in the development and oversight of the research support infrastructure;develop, implement, and maintain policies and procedures;coordinate the submission of grants and related site visits;and serve as a liaison to and primary point of contact with both internal units and external agencies. Funding from the CCSG supports a percentage of the salary of the Center Administrator, the Director's Executive Associate, and other administrative staff.
The Office of Administration coordinates and manages services important for the efficient and productive functioning of the SJCCC. This role is crucial in the global effort to advance the research and treatment of pediatric malignant diseases.
|Hatfield, M Jason; Binder, Randall J; Gannon, Rowan et al. (2018) Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza (""Danshen""). J Nat Prod 81:2410-2418|
|Vo, BaoHan T; Kwon, Jin Ah; Li, Chunliang et al. (2018) Mouse medulloblastoma driven by CRISPR activation of cellular Myc. Sci Rep 8:8733|
|Shadrick, William R; Slavish, Peter J; Chai, Sergio C et al. (2018) Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors. Bioorg Med Chem 26:25-36|
|Ramsey, Laura B; Balis, Frank M; O'Brien, Maureen M et al. (2018) Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. Oncologist 23:52-61|
|Churchman, Michelle L; Qian, Maoxiang; Te Kronnie, Geertruy et al. (2018) Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. Cancer Cell 33:937-948.e8|
|Huang, I-Chan; Brinkman, Tara M; Mullins, Larry et al. (2018) Child symptoms, parent behaviors, and family strain in long-term survivors of childhood acute lymphoblastic leukemia. Psychooncology 27:2031-2038|
|Huang, I-Chan; Klosky, James L; Young, Chelsea M et al. (2018) Misclassification of self-reported smoking in adult survivors of childhood cancer. Pediatr Blood Cancer 65:e27240|
|Mandrell, Belinda N; Avent, Yvonne; Walker, Breya et al. (2018) In-home salivary melatonin collection: Methodology for children and adolescents. Dev Psychobiol 60:118-122|
|Drummond, Catherine J; Hanna, Jason A; Garcia, Matthew R et al. (2018) Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. Cancer Cell 33:108-124.e5|
|Jones, Conor M; Baker, Justin N; Keesey, Rachel M et al. (2018) Importance ratings on patient-reported outcome items for survivorship care: comparison between pediatric cancer survivors, parents, and clinicians. Qual Life Res 27:1877-1884|
Showing the most recent 10 out of 6764 publications